Review article: targeting the B cell activation system in autoimmune hepatitis

Area of Science:

• Immunology
• Hepatology
• Autoimmune Diseases

Background:

• The B cell activation system, comprising B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), may contribute to the pathogenesis of autoimmune hepatitis.
• Understanding the role of BAFF and APRIL in immune responses is crucial for autoimmune disease research.

Purpose of the Study:

• To elucidate the biological functions of the BAFF/APRIL system.
• To investigate the involvement of BAFF and APRIL in autoimmune diseases.
• To assess the potential of targeting the BAFF/APRIL system therapeutically in autoimmune hepatitis.

Main Methods:

• Systematic literature search of English abstracts in PubMed.
• Selection and review of full-length articles.
• Development of secondary and tertiary bibliographies for comprehensive analysis.

Main Results:

• BAFF is essential for B cell maturation, survival, and T cell co-stimulation, and influences regulatory B cells.
• APRIL diversifies antibody responses and enhances T cell proliferation and survival.
• The BAFF/APRIL system is implicated in various autoimmune diseases, with blockade strategies under evaluation for autoimmune hepatitis.

Conclusions:

• The B cell activation system significantly impacts B and T cell functions in autoimmune conditions.
• Blockade therapy targeting the BAFF/APRIL system is a promising avenue for autoimmune hepatitis treatment.
• Further research into the specific pathogenic components of the BAFF/APRIL system will refine blockade therapy efficacy and safety.